You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tumor antigens

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Will Permit Sites to Proactively Assess TAA, HLA and HPV-16

Terminated
  • Head and Neck Cancer
  • +7 more
  • Tumor Profiling
  • Scottsdale, Arizona
  • +2 more
Dec 2, 2022

Metastatic Melanoma Trial in Irvine, Newport Beach (AV-MEL-1)

Recruiting
  • Metastatic Melanoma
  • Irvine, California
  • +1 more
Dec 14, 2021

Melanoma Trial in Germany (Lipo-MERIT)

Active, not recruiting
  • Melanoma
  • Lipo-MERIT
  • Frankfurt, Germany
  • +3 more
Jan 5, 2023

A Screening Study Targeting Tumor-specific Antigens

Recruiting
  • Metastatic Colorectal Cancer
  • Stage II/III Colon Cancer
  • blood collection for research (next generation sequencing [NGS])
  • +2 more
  • Los Angeles, California
  • +6 more
Dec 2, 2021

Stage III Ovarian Carcinoma, Stage IV Ovarian Carcinoma, Fallopian Tube Carcinoma Trial in United States (AVOVA-1, MC)

Active, not recruiting
  • Stage III Ovarian Carcinoma
  • +3 more
  • AVOVA-1
  • MC
  • Burbank, California
  • +5 more
Apr 21, 2022

Melanoma, Uveal Metastatic Trial in Erlangen (Vaccination with IKKb matured Dendritic Cells)

Active, not recruiting
  • Melanoma, Uveal Metastatic
  • Vaccination with IKKb matured Dendritic Cells
  • Erlangen, Bavaria, Germany
    University Hospital Erlangen Dept. of Dermatology
Mar 16, 2022

Newly Diagnosed Glioblastoma Trial in United States (AV-GBM-1)

Active, not recruiting
  • Newly Diagnosed Glioblastoma
  • AV-GBM-1
  • La Jolla, California
  • +7 more
Dec 14, 2021

Colon Cancer Metastatic, Head Neck Cancer Metastatic, Metastatic NSCLC Trial in United States (ADXS-NEO)

Unknown status
  • Colon Cancer Metastatic
  • +4 more
  • ADXS-NEO
  • Scottsdale, Arizona
  • +3 more
Aug 10, 2020

Glioma, Malignant Glioma of Brain, Recurrence Tumor Trial in Beijing (chimeric antigen receptor T cells)

Recruiting
  • Glioma
  • +2 more
  • chimeric antigen receptor T cells
  • Beijing, China
    Xuanwu Hospital
Jun 12, 2021

CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers

Active, not recruiting
  • Prostate Cancer
  • +3 more
  • blood and FFPE sample collection
  • Ancona, AN, Italy
  • +8 more
Feb 25, 2021

Liver Cancer, Lung Cancer, Breast Cancer Trial in Guangzhou (TILs and CAR-TILs targeting HER2, Mesothelin, PSCA, MUC1, Lewis-Y,

Recruiting
  • Liver Cancer
  • +7 more
  • TILs and CAR-TILs targeting HER2, Mesothelin, PSCA, MUC1, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2/6, ROR1, GD1, or B7-H3
  • Guangzhou, China
    Second Affiliated Hospital of Guangzhou Medical University
Apr 9, 2021

Non Small Cell Lung Cancer Trial in Durham (Ipilimumab, Paclitaxel, Cisplatin, Carboplatin)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Durham, North Carolina
    Duke University Medical Center
Feb 24, 2021

Detect and Expunge Concealed Tumors of the Liver

Recruiting
  • Liver Cancer
    • Hanoi, Vietnam
      108 Military Central Hospital
    Nov 15, 2023

    Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Cryoablation
    • Cryoablation combined with PD1 Inhibitor
    • (no location specified)
    Mar 28, 2023

    Brain Cancer, Tumor Metastases Trial in Guangzhou (Personalized cellular vaccine)

    Completed
    • Brain Cancer
    • Neoplasm Metastases
    • Personalized cellular vaccine
    • Guangzhou, Guangdong, China
      Guangdong 999 Brain Hospital
    May 23, 2022

    NSCLC Metastatic, Cryotherapy Effect Trial in Montreal (Cryo-activation, Pembrolizumab)

    Recruiting
    • Non-small Cell Lung Cancer Metastatic
    • Cryotherapy Effect
    • Montreal, Quebec, Canada
      Centre hospitalier de l'Université de Montréal (CHUM)
    Jun 22, 2022

    Upper Aerodigestive Malignancies

    Recruiting
    • Head and Neck Cancer
    • +2 more
    • Collection of biological specimens
    • Baltimore, Maryland
      Johns Hopkins University
    Aug 9, 2023

    Glioblastoma, Glioma Trial in New York (Bevacizumab, Peptide Vaccine, Poly-ICLC as immune adjuvant)

    Withdrawn
    • Glioblastoma
    • Glioma
    • New York, New York
      NYU Perlmutter Cancer Center
    Jan 8, 2020

    NSCLC Trial in Munich (Bone marrow aspiration from the iliac crest, Illinois bone marrow aspiration neddle)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Bone marrow aspiration from the iliac crest
    • Illinois bone marrow aspiration neddle
    • Munich, Germany
      Division of Thoracic Surgery, Technical University of Munich, Mu
    May 16, 2022

    Advanced Liver Cancers Trial (DC-CIK)

    Not yet recruiting
    • Advanced Liver Cancers
    • DC-CIK
    • (no location specified)
    Nov 11, 2022

    NSCLC Stage I Trial in Baltimore (Post-SABR Biopsy)

    Recruiting
    • Non-small Cell Lung Cancer Stage I
    • Post-SABR Biopsy
    • Baltimore, Maryland
      Bayview Medical Center
    Nov 23, 2021

    Sarcoma, Tumors, Connective and Soft Tissue Trial in Saint-Petersburg (Autologous dendritic cell vaccine)

    Unknown status
    • Sarcoma
    • Neoplasms, Connective and Soft Tissue
    • Autologous dendritic cell vaccine
    • Saint-Petersburg, Russian Federation
      N. N. Petrov Research Institute of oncology
    Nov 18, 2019

    New Antigens Against Glioblastoma

    Not yet recruiting
    • Glioblastoma Multiforme
      • (no location specified)
      Jun 15, 2023

      Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

      Not yet recruiting
      • Epithelial Ovarian Cancer
      • Ovarian Carcinoma
      • XP-DC vaccinations
      • Nijmegen, Gelderland, Netherlands
        Radboud University Medical Center
      Mar 6, 2023

      Tumor Antigen Expression Profiling and HLA Typing for

      Recruiting
      • Solid and Hematological Malignancies
        • Duarte, California
        • +34 more
        Aug 23, 2022